Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Neal, R. E., Singh, R., Hatcher, H. C., Kock, N. D., Torti, S. V., & Davalos, R. V. Breast Cancer Res Treat, 123(1):295-301, 2010. 1573-7217 Neal, Robert E 2nd Singh, Ravi Hatcher, Heather C Kock, Nancy D Torti, Suzy V Davalos, Rafael V R01 CA128428/CA/NCI NIH HHS/United States T32 CA079448/CA/NCI NIH HHS/United States R01CA12842/CA/NCI NIH HHS/United States T32 CA-079448/CA/NCI NIH HHS/United States R01 CA128428-03/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Netherlands 2010/03/02 Breast Cancer Res Treat. 2010 Aug;123(1):295-301. doi: 10.1007/s10549-010-0803-5. Epub 2010 Feb 27.
doi  abstract   bibtex   
Irreversible electroporation (IRE) is a therapeutic technology for the ablation of soft tissues using electrodes to deliver intense but short electric pulses across a cell membrane, creating nanopores that lead to cell death. This phenomenon only affects the cell membrane, leaving the extracellular matrix and sensitive structures intact, making it a promising technique for the treatment many types of tumors. In this paper, we present the first in vivo study to achieve tumor regression using a translatable, clinically relevant single needle electrode for treatment administration. Numerical models of the electric field distribution for the protocol used suggest that a 1000 V/cm field threshold is sufficient to treat a tumor, and that the electric field distribution will slightly decrease if the same protocol were used on a tumor deep seated within a human breast. Tumor regression was observed in 5 out of 7 MDA-MB231 human mammary tumors orthotopically implanted in female Nu/Nu mice, with continued growth in controls.
@article{RN232,
   author = {Neal, R. E., 2nd and Singh, R. and Hatcher, H. C. and Kock, N. D. and Torti, S. V. and Davalos, R. V.},
   title = {Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode},
   journal = {Breast Cancer Res Treat},
   volume = {123},
   number = {1},
   pages = {295-301},
   note = {1573-7217
Neal, Robert E 2nd
Singh, Ravi
Hatcher, Heather C
Kock, Nancy D
Torti, Suzy V
Davalos, Rafael V
R01 CA128428/CA/NCI NIH HHS/United States
T32 CA079448/CA/NCI NIH HHS/United States
R01CA12842/CA/NCI NIH HHS/United States
T32 CA-079448/CA/NCI NIH HHS/United States
R01 CA128428-03/CA/NCI NIH HHS/United States
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Netherlands
2010/03/02
Breast Cancer Res Treat. 2010 Aug;123(1):295-301. doi: 10.1007/s10549-010-0803-5. Epub 2010 Feb 27.},
   abstract = {Irreversible electroporation (IRE) is a therapeutic technology for the ablation of soft tissues using electrodes to deliver intense but short electric pulses across a cell membrane, creating nanopores that lead to cell death. This phenomenon only affects the cell membrane, leaving the extracellular matrix and sensitive structures intact, making it a promising technique for the treatment many types of tumors. In this paper, we present the first in vivo study to achieve tumor regression using a translatable, clinically relevant single needle electrode for treatment administration. Numerical models of the electric field distribution for the protocol used suggest that a 1000 V/cm field threshold is sufficient to treat a tumor, and that the electric field distribution will slightly decrease if the same protocol were used on a tumor deep seated within a human breast. Tumor regression was observed in 5 out of 7 MDA-MB231 human mammary tumors orthotopically implanted in female Nu/Nu mice, with continued growth in controls.},
   keywords = {Animals
Cell Line, Tumor
Electrochemotherapy/*instrumentation/*methods
Electrodes
Female
Humans
Mammary Neoplasms, Experimental/pathology/*therapy
Mice
Mice, Nude
*Needles
Xenograft Model Antitumor Assays},
   ISSN = {0167-6806 (Print)
0167-6806},
   DOI = {10.1007/s10549-010-0803-5},
   year = {2010},
   type = {Journal Article}
}

Downloads: 0